Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia
Belén Ansoleaga1, Paula Garcia-Esparcia1, Raquel Pinacho2
1Institut de Neuropatologia, IDIBELL-Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Abstract:
We have recently identified up- or down-regulation of the olfactory (OR) and taste (TASR) chemoreceptors in the human cortex in several neurodegenerative diseases, raising the possibility of a general deregulation of these genes in neuropsychiatric disorders. In this study, we explore the possible deregulation of OR and TASR gene expression in the dorsolateral prefrontal cortex in schizophrenia. We used quantitative polymerase chain reaction on extracts from postmortem dorsolateral prefrontal cortex of subjects with chronic schizophrenia (n = 15) compared to control individuals (n = 14). Negative symptoms were evaluated premortem by the Positive and Negative Syndrome and the Clinical Global Impression Schizophrenia Scales. We report that ORs and TASRs are deregulated in the dorsolateral prefrontal cortex in schizophrenia. Seven out of eleven ORs and four out of six TASRs were down-regulated in schizophrenia, the most prominent changes of which were found in genes from the 11p15.4 locus. The expression did not associate with negative symptom clinical scores or the duration of the illness. However, most ORs and all TASRs inversely associated with the daily chlorpromazine dose. This study identifies for the first time a decrease in brain ORs and TASRs in schizophrenia, a neuropsychiatric disease not linked to abnormal protein aggregates, suggesting that the deregulation of these receptors is associated with altered cognition of these disorders. In addition, the influence of antipsychotics on the expression of ORs and TASRs in schizophrenia suggests that these receptors could be involved in the mechanism of action or side effects of antipsychotics.
Insights
Olfactory (OR) and taste (TASR) receptors are down-regulated in the brain in schizophrenia. This finding suggests their involvement in altered cognition and potential antipsychotic mechanisms in this neuropsychiatric disorder.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Olfactory (OR) and taste (TASR) chemoreceptors show altered expression in neurodegenerative diseases.
- This suggests a potential role for these receptors in broader neuropsychiatric disorders.
Purpose of the Study:
- To investigate the deregulation of OR and TASR gene expression in the dorsolateral prefrontal cortex (DLPFC) in schizophrenia.
- To explore the association between gene expression, clinical symptoms, and antipsychotic treatment.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) was used on postmortem DLPFC tissue.
- Subjects included individuals with chronic schizophrenia (n=15) and controls (n=14).
- Clinical data, including negative symptoms and chlorpromazine dose, were analyzed.
Main Results:
- A significant down-regulation of 7/11 ORs and 4/6 TASRs was observed in schizophrenia patients.
- The most pronounced changes were linked to genes at the 11p15.4 locus.
- Gene expression changes did not correlate with symptom severity or illness duration but inversely associated with chlorpromazine dose.
Conclusions:
- This study provides the first evidence of decreased brain ORs and TASRs in schizophrenia.
- The findings suggest a role for these receptors in altered cognition associated with schizophrenia.
- OR and TASR expression may be influenced by antipsychotic medications, indicating their potential involvement in treatment mechanisms or side effects.
Related Concept Videos
Olfaction
The olfactory receptors are embedded in the cilia of the...
Olfactory Receptors: Location and Structure
Physiology of Smell and Olfactory Pathway
The olfactory...
Taste Buds and Receptors
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...


